News
BMS Announces Update on CheckMate -915 Evaluating Opdivo Plus...
Bristol Myers Squibb announced results for the co-primary endpoint for CheckMate -915, a randomized Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) versus Opdivo...
News
EMA starts first rolling review of a COVID-19 vaccine...
EMA’s human medicines committee (CHMP) has started the first ‘rolling review’ of a COVID-19 vaccine, which is being developed by the company AstraZeneca in collaboration...
News
AstraZeneca: COVID-19 vaccine AZD1222 clinical trial resumed in Japan,...
The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
A...
News
BIAL Goes Global with New US Research Center and...
BIAL, a pharmaceutical company based in Portugal with locations across Europe and dedicated to R&D in CNS diseases, announced that it has established a new...
News
Dr. Reddy’s Laboratories Announces the Launch of Cinacalcet Tablets...
Dr. Reddy’s Laboratories Ltd. announced the launch of Cinacalcet Tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets, approved by the U.S. Food and...
News
Syntegon goes live at PACK EXPO Connects 2020
Since the in-person PACK EXPO International and Healthcare Packaging EXPO have been cancelled, the process and packaging technology specialist Syntegon is presenting its latest solutions...
News
Suriname developed a high quality plasma COVID-19 treatment procedure...
The Academic Medical Center (AZP) in Paramaribo, Suriname, successfully studied an efficient method to collect COVID-19 antibody-containing plasma from recovered Covid-19 patients to treat critically...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.